Results 131 to 140 of about 7,640 (170)
Natural compounds of medicinal plants as a source for novel anti-orthopoxvirus medications. [PDF]
Life MedMakhlouf EA +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
JAMA - Journal of the American Medical Association, 2023
This JAMA Patient Page describes the eligibility, safety and effectiveness, and administration procedure for the JYNNEOS vaccine for mpox infection.
Angel N, Desai, Preeti N, Malani
exaly +3 more sources
This JAMA Patient Page describes the eligibility, safety and effectiveness, and administration procedure for the JYNNEOS vaccine for mpox infection.
Angel N, Desai, Preeti N, Malani
exaly +3 more sources
Predictors of laboratory-confirmed mpox in people with mpox-like illness
Clinical Microbiology and Infection, 2023We aimed to identify predictors of confirmed monkeypox (mpox) among people with mpox-like illness and to develop a multivariable model for confirmed mpox.We performed an observational study using national epidemiologic surveillance data in Mexico from May to November 2022.
Isaac Nunez
exaly +3 more sources
New England Journal of Medicine, 2023
Abstract Human mpox (formerly known as monkeypox) is a zoonotic disease that causes a smallpox-like infection in humans. The mpox virus, the causative agent of mpox, was first reported to cause human disease in a 9-month-old infant in the Democratic Republic of the Congo in 1970.
Mridula, Nadamuni, Lindsey, Baden
+7 more sources
Abstract Human mpox (formerly known as monkeypox) is a zoonotic disease that causes a smallpox-like infection in humans. The mpox virus, the causative agent of mpox, was first reported to cause human disease in a 9-month-old infant in the Democratic Republic of the Congo in 1970.
Mridula, Nadamuni, Lindsey, Baden
+7 more sources
Clinics in Dermatology
Mpox, a zoonotic orthopoxvirus, originally identified in 1958, exhibits two distinct genetic strains or clades, clades 1 and 2. Before 2022, mpox was predominantly isolated in the endemic regions of West and Central Africa. Sporadic outbreaks of travel-associated clade 2 mpox had previously occurred in nonendemic areas, but persistent human-to-human ...
Joseph, Heskin +3 more
openaire +2 more sources
Mpox, a zoonotic orthopoxvirus, originally identified in 1958, exhibits two distinct genetic strains or clades, clades 1 and 2. Before 2022, mpox was predominantly isolated in the endemic regions of West and Central Africa. Sporadic outbreaks of travel-associated clade 2 mpox had previously occurred in nonendemic areas, but persistent human-to-human ...
Joseph, Heskin +3 more
openaire +2 more sources
Tecovirimat for the Treatment of Mpox
New England Journal of MedicineTecovirimat is approved for smallpox treatment under the Food and Drug Administration Animal Rule on the basis of efficacy in nonhuman primate models of mpox (previously known as monkeypox). However, the clinical efficacy of tecovirimat against human clade II mpox is unclear.In a phase 3, international, double-blind, randomized, placebo-controlled ...
Jason Zucker +26 more
openaire +2 more sources
The Resurgence of Mpox in Africa
JAMAThis Viewpoint discusses the current mpox outbreak in Africa and why countries worldwide must urgently act to address it after the World Health Organization declared the event a Public Health Emergency of International Concern.
Caitlin, Rivers +2 more
openaire +2 more sources